VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $2,024,518 (100.0% shares, 0.0% debt)

Holdings (27)

New Positions (1)

Increased Positions (7)

Unchanged Positions (15)

APGE APOGEE THERAPEUTICS INC 31.7%
Value ($000) $641,076 Shares 8,493,321 Est. Cost $22.03 Unrealized +185.9%
ORKA ORUKA THERAPEUTICS INC 6.2%
Value ($000) $125,739 Shares 4,148,428 Est. Cost $29.65 Unrealized -6.0%
VRDN VIRIDIAN THERAPEUTICS INC 6.0%
Value ($000) $120,830 Shares 3,882,709 Est. Cost $19.32 Unrealized +42.0%
ERAS ERASCA INC 3.3%
Value ($000) $66,428 Shares 17,857,083 Est. Cost $2.08 Unrealized +35.1%
KALV KALVISTA PHARMACEUTICALS INC 5.4%
Value ($000) $108,673 Shares 6,728,985 Est. Cost $8.91 Unrealized +48.7%
JBIO JADE BIOSCIENCES INC 2.5%
Value ($000) $49,690 Shares 3,220,364 Est. Cost $33.31 Unrealized -64.8%
CTMX CYTOMX THERAPEUTICS INC 3.3%
Value ($000) $66,292 Shares 15,561,500 Est. Cost $1.68 Unrealized +126.5%
ELVN ENLIVEN THERAPEUTICS INC 2.5%
Value ($000) $49,685 Shares 3,226,331 Est. Cost $18.38 Unrealized +8.4%
DYN DYNE THERAPEUTICS INC 2.1%
Value ($000) $42,522 Shares 2,173,913 Est. Cost $11.80 Unrealized +60.5%
UPB UPSTREAM BIO INC 1.6%
Value ($000) $31,746 Shares 1,169,298 Est. Cost $22.33 Unrealized +11.5%
SRZN SURROZEN INC 0.7%
Value ($000) $14,304 Shares 632,931 Est. Cost $11.62 Unrealized +39.2%
CGEM CULLINAN THERAPEUTICS INC 0.7%
Value ($000) $14,283 Shares 1,379,965 Est. Cost $21.29 Unrealized -57.6%
SEPN SEPTERNA INC 0.8%
Value ($000) $17,029 Shares 610,808 Est. Cost $8.80 Unrealized +171.5%
ARTV ARTIVA BIOTHERAPEUTICS INC 0.3%
Value ($000) $6,905 Shares 1,609,569 Est. Cost $11.59 Unrealized -67.4%
CASI CASI PHARMACEUTICALS INC 0.0%
Value ($000) $839 Shares 987,259 Est. Cost $6.09 Unrealized -78.8%